Anlotinib is an anti-tumor prescription drug primarily indicated for the treatment of specific cancers (e.g., non-small cell lung cancer, soft tissue sarcoma, etc.). It is available for purchase only with a valid doctor’s prescription. Authorized purchase channels include hospital pharmacies, licensed chain pharmacies, and qualified online platforms. Patients must strictly follow medication guidelines and doctor’s instructions, and must not self-administer the drug.
Purchase Methods and Self-Verification
1. Hospital Pharmacies
Indications for Use: For patients diagnosed with cancer and assessed by a physician as needing anlotinib treatment.
Self-Verification: Confirm that pathological diagnosis has been completed in the hospital and a prescription has been issued.
2. Licensed Pharmacies (Offline/Online)
Indications for Use: For patients who already hold a valid doctor’s prescription.
Self-Verification:
For offline pharmacies: Verify that the pharmacy holds a valid Drug Distribution License.
For online platforms: Check the drug traceability code to authenticate the medication.
3. Medication List (Generic Name)
Anlotinib Hydrochloride Capsules (dosage strength to be selected per doctor’s order, e.g., 8mg, 10mg, 12mg).
Precautions
Strictly Follow Doctor’s Instructions: Dosage and treatment course must be adjusted based on disease conditions. Do not arbitrarily increase, decrease the dose, or discontinue the medication.
Contraindications and Adverse Reactions: Monitor blood pressure and coagulation function during treatment. Avoid concurrent use with anticoagulants. Common adverse reactions include hypertension, fatigue, and hand-foot syndrome.
Channel Compliance: Beware of medications from unauthorized channels to avoid the risk of counterfeit drugs. For online purchases, select platforms filed with the drug regulatory authority.
If you have not yet received a diagnosis or obtained a prescription, please consult an oncologist promptly. The treatment plan should be determined only after confirming the indication through pathological examination.